Bio Pharma Dive
OCTOBER 20, 2023
With the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential for antibody-drug conjugates to reshape cancer treatment.
Pharmaceutical Technology
OCTOBER 20, 2023
NVIDIA’s vice-president of healthcare, Kimberly Powell, discussed GenAI in pharma and the importance of partnerships.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 20, 2023
The deal is worth up to $22 billion in total, making it one of the largest pharmaceutical licensing agreements by value.
Pharmaceutical Technology
OCTOBER 20, 2023
Health Canada has granted a Notice of Compliance (NOC) to Sumitomo Pharma Canada and Pfizer Canada’s MYFEMBREE.
Rethinking Clinical Trials
OCTOBER 20, 2023
How Do You Design Trials That Are Fit for Purpose? Description Dr. Lesley Curtis discusses how to design trials that are fit for purpose. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair The post How Do You Design Trials That Are Fit for Purpose?
Pharmaceutical Technology
OCTOBER 20, 2023
Daiichi Sankyo will receive an upfront payment of $4bn and will be eligible for additional milestone payments of up to $22bn.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 20, 2023
The company plans to initiate the Phase II trial of anti-IL-6 antibody in atherosclerotic cardiovascular disease in 2024.
Outsourcing Pharma
OCTOBER 20, 2023
The treatment of rare brain disease, progressive supranuclear palsy (PSP), that has no disease modifying therapies, has been given a glimmer of hope by Amylyx Pharmaceuticals.
Pharmaceutical Technology
OCTOBER 20, 2023
Endeavor BioMedicines has acquired exclusive global rights to the HER3-targeted antibody-drug conjugate (ADC) of Hummingbird Bio, HMBD-501.
Pharma Times
OCTOBER 20, 2023
The new technology was safely trialled on 20 healthy volunteers for the first time ever - News - PharmaTimes
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 20, 2023
The company has said that it is ready to launch a Phase IIa trial with the drug being intended to treat an often painful condition.
Fierce Pharma
OCTOBER 20, 2023
Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers. | Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers.
Pharmaceutical Technology
OCTOBER 20, 2023
The European Commission (EC) has granted unconditional approval to Pfizer for the prospective takeover of Seagen for $43bn in cash.
Intouch Solutions
OCTOBER 20, 2023
This year’s Dreamforce conference – the annual gathering for Salesforce, one of the main providers in commercial marketing and sales technology for the Health & Life Science (HLS) industry – was bigger and more innovative than ever. But what news will matter most for health & life sciences companies? An EVERSANA INTOUCH team attends each year to get the latest on the technologies coming to market and to get inspired on the best ways to use them for our clients.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
OCTOBER 20, 2023
Over 20,000 people and businesses in the UK have already been approached by Chinese spies, warned MI5 head Ken McCallum.
Pharma Times
OCTOBER 20, 2023
Global innovators can apply to PACE to receive up to £1m per project - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 20, 2023
Meilleur’s [F-18]NAV-4694 will be used as a biomarker in ADNI4’s Alzheimer’s disease research.
Outsourcing Pharma
OCTOBER 20, 2023
Feedback has been submitted to the US Food and Drug Administration (FDA) with guidelines intended for sponsors of clinical trials related to psychedelic compounds.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
OCTOBER 20, 2023
UCB’s drug is the first IL-17A and IL-17F inhibitor approved for patients with moderate to severe plaque psoriasis.
Fierce Pharma
OCTOBER 20, 2023
In the race to secure U.S. approval for the first five-pronged meningitis vaccine, Pfizer has eked out a regulatory win well ahead of its immunization rival GSK. | The U.S. FDA gave a thumbs-up to Penbraya, the commercial moniker for Pfizer’s pentavalent vaccine defending against the most common serogroups behind meningococcal disease. The shot is approved for adolescents and adults between the ages of 10 and 25.
Pharmaceutical Technology
OCTOBER 20, 2023
Roche has posted a 7% rise in group sales to SFr14.27bn ($15.91bn) at constant exchange rates (CER) in Q3 2023.
pharmaphorum
OCTOBER 20, 2023
At CAR-TCR last month in Boston, pharmaphorum Editor in Chief Jonah Comstock grabbed some time with Tim McGuire, director of business development at biomanufacturer Resilience.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioPharma Reporter
OCTOBER 20, 2023
Researchers at the UK Dementia Research Institute have developed a new form of deep brain stimulation that does not require surgery and could provide an alternative treatment option for debilitating brain diseases such as Alzheimerâs.
Outsourcing Pharma
OCTOBER 20, 2023
Dave Hine is the senior director of sales and engineering at Greenphire. He has been reflecting on his time at DPharm and the collaborative approach to life sciences.
Fierce Pharma
OCTOBER 20, 2023
In September, Eli Lilly filed lawsuits against eight com | Eli Lilly is going after 11 online pharmacies—including several overseas—that are allegedly importing, selling or distributing unauthorized versions of its diabetes drug Mounjaro. In a complaint filed with the U.S. International Trade Commission, Lilly has named three companies in China, three in Europe and five in the U.S. that it claims are selling “low-grade” versions of the drug.
Outsourcing Pharma
OCTOBER 20, 2023
Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Channels
OCTOBER 20, 2023
Today’s guest post comes from Melanie Christie, VP of Product Management at CoverMyMeds. Melanie discusses how the nationwide shortage of pharmacy technicians affects pharmacists. She argues that centralized prescription fulfillment can provide pharmacists with more time to care for patients while also reducing medication errors and accelerating time-to-treatment.
Outsourcing Pharma
OCTOBER 20, 2023
A small molecule kinase inhibitor has been trialed in humans for the first time as part of a glioblastoma treatment study.
Fierce Pharma
OCTOBER 20, 2023
At ESMO, Merck is encouraged by Welireg's potential to treat clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer.
Drug Patent Watch
OCTOBER 20, 2023
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent… The post New tentative approval for Sandoz drug sugammadex sodium appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
264 
Let's personalize your content